September 27

PARIS, September 27, 2011 - - Five-year data from Research in Severe Asthma (RISA) Trial demonstrate maintenance ofstable lung function and absence of late clinical complications - Patients in Europe with severe asthma can now benefit from uniqueand proven non-drug therapy Boston Scientific Corporation (NYSE: BSX) announces positive clinical data from the Research in Severe Asthma (RISA) Trial, demonstrating the long-term safety of bronchial thermoplasty (BT) in patients treated with the Company's Alair™ Bronchial Thermoplasty System.

AMSTERDAM, September 27, 2011 - Atradius, one of the leading global credit insurers, has extended its pan-Asian partnership with Tokio Marine Asia Pte Ltd (TM Asia), following a period of sustained growth in the region, which now enables policies to be issued locally in Indonesia, Malaysia, Vietnam and the Philippines by TM Asia affiliated insurance companies.

OSLO, Norway, September 27, 2011 - Strategic collaboration with Ipsen for marketing rights in Europe and the rest of the world except Nordics and the US Photocure to commercialise the product directly in the US market Photocure ASA (OSE: PHO), a specialty pharmaceutical company focused on photodynamic technologies in dermatology and cancer, announces today the execution of a new commercial strategy for Hexvix, its flagship product to aid in diagnosing bladder cancer.

BIRMINGHAM, England, September 27, 2011 - CrossCountry trains has launched a mobile app that not only provides real time travel information across ALL rail networks - you can download your ticket to it too.

LONDON, September 27, 2011 - BetterQualified Applicants Don't Stand Out DuetoInadequateCVContent A white paper based on a survey conducted by TheLadders.co.uk of 134 executive level recruiters has given a clearer picture of how recruiters make their selections and what they expect to see in a CV from senior level candidates.